000 01317 a2200349 4500
005 20250516193107.0
264 0 _c20141229
008 201412s 0 0 eng d
022 _a2213-2619
024 7 _a10.1016/S2213-2600(13)70287-X
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGerges, Christian
245 0 0 _aChanging perceptions in pulmonary hypertension.
_h[electronic resource]
260 _bThe Lancet. Respiratory medicine
_cJan 2014
300 _a21-3 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAntihypertensive Agents
_xtherapeutic use
650 0 4 _aEndothelin Receptor Antagonists
_xtherapeutic use
650 0 4 _aHumans
650 0 4 _aHypertension, Pulmonary
_xdrug therapy
650 0 4 _aPulmonary Veno-Occlusive Disease
_xgenetics
650 0 4 _aPyrazoles
_xtherapeutic use
650 0 4 _aPyrimidines
_xtherapeutic use
650 0 4 _aRandomized Controlled Trials as Topic
650 0 4 _aSulfonamides
_xtherapeutic use
650 0 4 _aThromboembolism
_xdrug therapy
650 0 4 _aTreatment Failure
650 0 4 _aVasodilator Agents
_xtherapeutic use
700 1 _aLang, Irene M
773 0 _tThe Lancet. Respiratory medicine
_gvol. 2
_gno. 1
_gp. 21-3
856 4 0 _uhttps://doi.org/10.1016/S2213-2600(13)70287-X
_zAvailable from publisher's website
999 _c23483783
_d23483783